"Nov. 20, 2012 -- Oral contraceptives should be made available without a prescription to reduce unintended pregnancies, according to a newly published opinion by the American College of Obstetricians and Gynecologists (ACOG).
(norethindrone and ethinyl estradiol) Tablets, USP
Patients should be counseled that this product does not protect against HIV-infection (AIDS) and other sexually transmitted diseases.
OVCON® 50, 28-Day (norethindrone and ethinyl estradiol tablets, USP) provides a continuous regimen for oral contraception derived from 21 tablets composed of norethindrone and ethinyl estradiol to be followed by 7 green tablets of inert ingredients. The chemical name for norethindrone is 17-hydroxy-19-nor-17αpregn-4-en-20-yn-3-one and for ethinyl estradiol the chemical name is 19-nor-17α-pregna-1,3,5(10)-trien20-yne-3,17-diol. The structural formulas are:
The active OVCON (norethindrone and ethinyl estradiol tablets) 50 tablets contain 1 mg norethindrone and 0.05 mg ethinyl estradiol.
OVCON (norethindrone and ethinyl estradiol tablets) ® 50, 28-Day contains the following inactive ingredients: dibasic calcium phosphate, D&C Yellow No. 10 (aluminum lake), FD&C Blue No. 1 (aluminum lake), FD&C Yellow No. 6 (aluminum lake), lactose, magnesium stearate, povidone, sodium starch glycolate, starch (corn), and talc.
Last reviewed on RxList: 8/7/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Ovcon Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.